Chronic obstructive pulmonary disease has become a major global health concern. According to the World Health Organisation's November 2024 report, COPD remains the world's fourth largest cause of ...
(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results